Kevin Fischbeck

Bank of America Merrill Lynch's Kevin Fischbeck pounded the table on his bullish rating on shares of TeamHealth Holdings Inc (NYSE: TMH) in a research note Monday morning. Following Envision Healthcare Holdings Inc (NYSE: EVHC)'s deal for AmSurg, Fischbeck spent time with TeamHealth CFO...

Community Health Systems (NYSE: CYH) shares are down 50 percent year-to-date, slumping from $40 to $30 on October 21. BofA Merrill Lynch’s Kevin Fischbeck downgraded the rating on the company from Buy to Neutral, while reducing the price objective from $64 to $42. The company...

Cigna Corporation (NYSE: CI) is likely to ultimately accept a takeover bid by Anthem Inc (NYSE: ANTM), according to a couple of analysts Monday. Anthem's $47 billion cash-and-stock offer was initially rejected by Cigna on Sunday. But Susquehanna's Chris Rigg said Cigna won't...

In a report published Friday, Bank of America analyst Kevin Fischbeck reiterated a Neutral rating on Humana (NYSE: HUM), and raised the price target from $146.00 to $150.00. In the report, Bank of America noted, “Yesterday HUM held its biennial Investor Day. Overall, the tone was positive but the...

Bank of America on Tuesday raised price targets for several managed care companies. Analyst Kevin Fischbeck noted the firm’s monthly Trend Tracker with a “Q4 trend of 3.7 percent vs 3.8 percent in Q3” and the “PMPM trend controlled.” The “Trend Tracker...

The recent ramp-up in the Affordable Care Act, commonly referred to as Obamacare, benefits is boosting hospital admissions and lowering the number of "self-pay" patients and associated bad debt, an analyst said Monday. Top pick for Bank of America's Kevin Fischbeck is Community...

The second and third-largest U.S. health insurers diverged in the ratings of an investment bank Monday. Bank of America's Kevin Fischbeck boosted his rating on WellPoint Inc (NYSE: WLP) to Buy with a target of $140, while cutting his rating on Aetna Inc (NYSE: AET) to Neutral. Investors...

In a note released Monday morning, Bank of America analyst Kevin Fischbeck upgraded shares of WellPoint Inc (NYSE: WLP) from Neutral to Buy and raised the price objective from $125 to $140. Fischbeck wrote, "The current valuation overly discounts HC Reform risks and undervalues the company's growth...

In a report published Wednesday, Bank of America analyst Kevin Fischbeck reiterated a Buy rating and $66.00 price target on Team Health Holdings LLC (NYSE: TMH). In the report, Bank of America noted, “TMH announced it acquired Florida Gulf-to-Bay Anesthesiology Associates, a physician practice with...

In a report published Tuesday, Bank of America analyst Kevin Fischbeck reiterated a Buy rating and $16.00 price target on Health Insurance Innovations (NASDAQ: HIIQ). In the report, Bank of America noted, “HIIQ reported adj. Q2 EPS of $0.06 (ex $0.01 fair value adj to contingent consideration), $0....

In a report published Thursday, Bank of America analyst Kevin Fischbeck reiterated a Neutral rating on WellPoint (NYSE: WLP), and raised the price target from $120.00 to $125.00. In the report, Bank of America noted, “WLP reported adj. Q2 EPS of $2.44, $0.13 above our est and $0.18 above consensus...